EASTHAM KARIN 4
4 · VERACYTE, INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
EASTHAM KARIN
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-02$5.28/sh+10,000$52,800→ 28,497 total - Sale
Common Stock
2025-01-02$40.12/sh−5,309$213,010→ 23,188 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-02−10,000→ 0 totalExercise: $5.28Exp: 2026-06-20→ Common Stock (10,000 underlying) - Sale
Common Stock
2025-01-02$40.50/sh−4,691$189,996→ 18,497 total
Footnotes (4)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $39.46 to $40.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $40.37 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]The option is fully vested.